CDK2 and cancer: Furthermore, transfection of antisense oligonucleotide of miR-25 has downregulated the overexpressed miR-25 in SCLC cell line, resulting in decreased amount of cancer cell proliferation, invasion and resistance to cisplatin by suppressing the expression of cyclinE2 and CDK2 [5].